Gavin Newsom Underestimated Deadline for Bold Insulin Plan by Years
Although California's governor hoped to have the cheaper insulin available by last year, it may take at least another two years.
Hosted on MSN14d
Newsom committed California to making its own insulin. It’s at least a year behind his schedule
Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the schedule he announced and unlikely to make it to market for several ...
Capital Public Radio1d
CA Insulin Production Behind Schedule | Immigration Enforcement in California | NPR’s Student Podcast Challenge
Gov. Newsom’s first-in-the-nation plan to produce cheaper insulin is behind schedule. Also, how President Trump’s immigration ...
San Diego Reader7d
Newsom’s $100 million San Diego insulin give-away stalls
Newsom’s insulin fail. A drive by California Gov. Gavin Newsom to make low-cost insulin by spending $100 million in state ...
U.S. News & World Report15d
Newsom Committed California to Making Its Own Insulin. It’s at Least a Year Behind His Schedule
Newsom Committed California to Making Its Own Insulin. It’s at Least a Year Behind His Schedule Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million ...
Newsweek14d
Gavin Newsom Underestimated Deadline for Bold Insulin Plan by Years
California Governor Gavin Newsom's bold plan to produce cheap, generic insulin for Californians by 2024 could be delayed for years. Civica, the nonprofit drug manufacturer contracted to produce ...
Capital Public Radio14d
Newsom committed California to making its own insulin. It’s at least a year behind his schedule
Welcome to CalMatters, the only nonprofit newsroom devoted solely to covering issues that affect all Californians. Sign up for WhatMatters to receive the latest news and commentary on the most ...
Houston Chronicle15d
Newsom committed California to making its own insulin. It’s at least a year behind his schedule
Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the schedule he announced and unlikely to make it to market for ...